NCT04677608 Pulmonary Hypertension Modality of Death and Validation of REVEAL Risk Score Status UNKNOWN Phase N/A
NCT04675944 Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil Status COMPLETED Phase PHASE1
NCT04576988 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR) Status COMPLETED Phase PHASE3
NCT04570228 TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study Status NOT_YET_RECRUITING Phase NA
NCT04567602 A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or Selexipag Status COMPLETED Phase N/A
NCT04555161 Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System Status RECRUITING Phase NA
NCT04528056 Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension Status UNKNOWN Phase PHASE1/PHASE2
NCT04505137 A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04503733 A Study of GMA301 in Subjects With Pulmonary Arterial Hypertension Status UNKNOWN Phase PHASE1
NCT04489251 Assessment of the TGF-beta Pathway and Micro-RNA in Pediatric Pulmonary Arterial Hypertension Status UNKNOWN Phase N/A
NCT04483115 Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT04451850 HRV as a Marker of Treatment Response in PAH Arterial Hypertension Status COMPLETED Phase N/A
NCT04435782 A Study of Selexipag Assessing Right Ventricular Remodeling in Pulmonary Arterial Hypertension by Cardiac Magnetic Resonance Imaging Status TERMINATED Phase PHASE4
NCT04416750 Positioning Imatinib for Pulmonary Arterial Hypertension Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04316143 Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) Status COMPLETED Phase PHASE2
NCT04309838 Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension Status UNKNOWN Phase N/A
NCT04282434 DNA Methylation Dynamics Underlying Arterial Remodeling in PAH Patients: CLEOPAHTRA Clinical Trial Status COMPLETED Phase N/A